Anthropic IPO: Here are the early backers whose investments are now worth billions

Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Anthropic debuted on the Nasdaq Global Select Market on Thursday with a $1.5 trillion valuation.
- ✓The record-breaking IPO brought billions in returns for early backers like Iconiq, Spark Capital, and Menlo Ventures.
- ✓These firms got massive gains after they put in huge amounts of money to support the AI company.
Story at a Glance
- Category
- Indian Markets
- Reported By
- cnbctv18
- Reading Speed
- 4 Minute(s)
- Market Focus
- India Economy
Anthropic PBC's record-breaking IPO is set to bring in returns worth billions of dollars for several financial firms that bet the house on the Claude chatbox maker. The company, after its debut on Thursday on the Nasdaq Global Select Market, will be the first-ever frontier lab to go public. It priced its shares at $83 apiece, giving it an approximately $1.5 trillion valuation, up around $100 billion from the higher end of its previous range. Bloomberg has compiled a list of some of the largest and notable financial investors in Anthropic that stand to gain from the IPO. Here's what the report reveals:
Iconiq | A wealth management company turned Silicon Valley private markets investor has put in over $6 billion in Anthropic. It has previously backed OpenAI and it wrote its first check to Anthropic last year, when the company was valued at $183 billion, which is now just a fraction of its IPO price. Iconiq's $6 billion bet is its largest private investment ever. Based on its pre-IPO investments, Its stake in Anthropic would be worth more than $26 billion at the firm's $1.5 trillion IPO valuation.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
cnbctv18
Read the full, original unfiltered story directly on the publisher's portal.
This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.